Tech Company Financing Transactions

Civitas Therapeutics Funding Round

On 8/25/2014, Civitas Therapeutics landed $55 million in Series C funding from Adage Capital Management, Alkermes and Bay City Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The proceeds from this financing round will be used towards the upcoming Phase 3 clinical trials for our lead candidate, CVT-301, an inhaled formulation of levodopa (L-dopa) being developed for rapid and reliable relief from debilitating motor fluctuations, known as OFF episodes, associated with Parkinson's disease (PD), as well as for the development of additional, early stage pipeline programs.

Company Information

Company Status
Acquired or Merged
Mailing Address
190 Everett Ave.
Chelsea, MA 02150
Email Address
Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device.
Civitas Therapeutics LinkedIn Company Profile
Social Media
Civitas Therapeutics Company Twitter Account
Company News
Civitas Therapeutics News
Civitas Therapeutics on Facebook
Civitas Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Mark Iwicki
  Mark Iwicki LinkedIn Profile  Mark Iwicki Twitter Account  Mark Iwicki News  Mark Iwicki on Facebook
Chief Medical Officer
Martin Freed
  Martin Freed LinkedIn Profile  Martin Freed Twitter Account  Martin Freed News  Martin Freed on Facebook
Chief Scientific Officer
Rick Batycky
  Rick Batycky LinkedIn Profile  Rick Batycky Twitter Account  Rick Batycky News  Rick Batycky on Facebook
VP - Regulatory Affairs
Mary Taylor
  Mary Taylor LinkedIn Profile  Mary Taylor Twitter Account  Mary Taylor News  Mary Taylor on Facebook
VP - Sales
Bryan Stuart
  Bryan Stuart LinkedIn Profile  Bryan Stuart Twitter Account  Bryan Stuart News  Bryan Stuart on Facebook



Browse more venture capital transactions:

Prev: 8/25/2014: Zumigo venture capital transaction
Next: 8/25/2014: Symptomly venture capital transaction


Share this article


News on VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary